Prediction of Appropriate Implantable Cardioverter-Defibrillator Therapy Using Machine Learning and Routinely Available Clinical Data

Abstract Background and Aims Risk stratification for appropriate implantable cardioverter-defibrillator (ICD) therapy remains imprecise when based on conventional clinical variables alone. We aimed to develop and geographically validate a machine-learning model that integrates routinely available clinical, electrocardiogram, and device interrogation/programming parameters, and quantify the incremental value of non-sustained ventricular tachycardia (NSVT). Methods We retrospectively analysed 514 ICD recipients implanted between 2020 and 2025 at two hospital sites (development cohort) and an independent cohort of 220 patients from a third site (external validation). The endpoint was appropriate ICD therapy (anti-tachycardia pacing or shock). Models were trained using nested stratified cross-validation in the development cohort, and the final refitted model was applied to the external cohort without recalibration. Results In the development cohort, 77/514 patients (15%) experienced appropriate ICD therapy (follow-up 404 days). A base model (Histogram-based gradient boosting) excluding NSVT achieved modest discrimination (ROC-AUC 0.624; average precision 0.198). Adding NSVT improved performance (ROC-AUC 0.805; average precision 0.432). Logistic regression with NSVT achieved comparable discrimination (ROC-AUC 0.78; average precision 0.43), indicating a largely NSVT-driven gain. External validation (event rate 51/220, 23%) confirmed good discrimination (ROC-AUC 0.815; average precision 0.583) with acceptable calibration (Brier score 0.137). At prespecified threshold 0.16 in external validation, sensitivity was 0.78 and specificity 0.74. Conclusion A machine-learning model integrating routinely available clinical, electrocardiogram, and ICD programming/interrogation data may enable prediction of appropriate ICD therapy with preserved performance on geographic external validation. NSVT was the dominant contributor to predictive performance across modelling approaches.

Authors

Institutions

Publication Details

Journal
European Heart Journal - Digital Health
Published
2026-06-25
DOI
https://doi.org/10.1093/ehjdh/ztag102
Primary Topic
Cardiac pacing and defibrillation studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prediction of Appropriate Implantable Cardioverter-Defibrillator Therapy Using Machine Learning and Routinely Available Clinical Data

Toshinori Chiba, Emanuel Heil, Verena Tscholl, Robert Hättasch et al.
European Heart Journal - Digital Health
Cardiac pacing and defibrillation studies
article

Prediction of Appropriate Implantable Cardioverter-Defibrillator Therapy Using Machine Learning and Routinely Available Clinical Data

Toshinori Chiba, Emanuel Heil, Verena Tscholl, Robert Hättasch, Johannes Lucas, Gerhard Hindricks, Patrick Nagel, Felix Hohendanner, Felix Balzer, Nikolaos Dagres, Wilhelm Haverkamp, Alexander Meyer, F Blaschke, S Wegner
article en

Abstract

Abstract Background and Aims Risk stratification for appropriate implantable cardioverter-defibrillator (ICD) therapy remains imprecise when based on conventional clinical variables alone. We aimed to develop and geographically validate a machine-learning model that integrates routinely available clinical, electrocardiogram, and device interrogation/programming parameters, and quantify the incremental value of non-sustained ventricular tachycardia (NSVT). Methods We retrospectively analysed 514 ICD recipients implanted between 2020 and 2025 at two hospital sites (development cohort) and an independent cohort of 220 patients from a third site (external validation). The endpoint was appropriate ICD therapy (anti-tachycardia pacing or shock). Models were trained using nested stratified cross-validation in the development cohort, and the final refitted model was applied to the external cohort without recalibration. Results In the development cohort, 77/514 patients (15%) experienced appropriate ICD therapy (follow-up 404 days). A base model (Histogram-based gradient boosting) excluding NSVT achieved modest discrimination (ROC-AUC 0.624; average precision 0.198). Adding NSVT improved performance (ROC-AUC 0.805; average precision 0.432). Logistic regression with NSVT achieved comparable discrimination (ROC-AUC 0.78; average precision 0.43), indicating a largely NSVT-driven gain. External validation (event rate 51/220, 23%) confirmed good discrimination (ROC-AUC 0.815; average precision 0.583) with acceptable calibration (Brier score 0.137). At prespecified threshold 0.16 in external validation, sensitivity was 0.78 and specificity 0.74. Conclusion A machine-learning model integrating routinely available clinical, electrocardiogram, and ICD programming/interrogation data may enable prediction of appropriate ICD therapy with preserved performance on geographic external validation. NSVT was the dominant contributor to predictive performance across modelling approaches.

European Heart Journal - Digital Health
Humboldt-Universität zu Berlin (DE), Deutsches Herzzentrum der Charité (DE), German Centre for Cardiovascular Research (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Charité - Universitätsmedizin Berlin (DE)
Peace, Justice and strong institutions
Openalex Percentile: Top 7%
Cardiac pacing and defibrillation studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.